• 2457 Citations
  • 24 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sang Won Shin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 51 Similar Profiles
Cisplatin Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Survival Medicine & Life Sciences
Leucovorin Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 2457 Citations
  • 24 h-Index
  • 100 Article
  • 18 Letter

Alpelisib for PIK3CA-mutated advanced breast cancer

Park, J. & Shin, S. W., 2019 Aug 15, In : New England Journal of Medicine. 381, 7, 1 p.

Research output: Contribution to journalLetter

Breast Neoplasms

Clinical and therapeutic implications of cancer stem cells

Shin, S. W., 2019 Sep 5, In : New England Journal of Medicine. 381, 10, p. E19

Research output: Contribution to journalLetter

Neoplasm Drug Resistance
Neoplastic Stem Cells
Therapeutics
Tumor Burden
Non-Small Cell Lung Carcinoma
DNA
Glycolysis
Survival

Hepatocellular carcinoma

Kim, Y. S. & Shin, S. W., 2019 Jul 4, In : New England Journal of Medicine. 381, 1, p. E2

Research output: Contribution to journalLetter

Hepatocellular Carcinoma

Lorcaserin Safety in Overweight or Obese Patients

Ham, S. Y. & Shin, S. W., 2019 Jan 3, In : The New England journal of medicine. 380, 1, 1 p.

Research output: Contribution to journalLetter

Benzazepines
Obesity
Safety
lorcaserin